Precious metals continue their historic surge, outpacing the S&P 500 for a third consecutive year. We examine the powerful drivers behind the rally, from industrial demand to monetary policy, and explore how investors can gain exposure through ETFs while navigating the risks.
President Donald Trump has nominated Kevin Warsh, a former Federal Reserve governor and critic of current monetary policy, to succeed Jerome Powell as Chair of the Federal Reserve, setting the stage for a potential shift in the central bank's direction.
While rising prices are felt at the checkout line, their long-term erosion of retirement savings is often overlooked. Experts warn that cumulative inflation across essential categories could create a six-figure shortfall for unprepared retirees.
The long-term strategic partnership will leverage IQVIA's data-as-a-service platform to unify and streamline commercial data across 59 countries, aiming to accelerate product launches and enhance decision-making for the pharmaceutical giant.
As one of the oldest cryptocurrencies, Dogecoin faces a critical juncture. With its price down over 80% from its 2021 peak and questions about its long-term utility mounting, investors are weighing whether the iconic digital asset has a future or is fading into irrelevance.
With the Federal Reserve holding rates steady and economic signals mixed, investors are looking beyond the S&P 500 for growth. We analyze three under-the-radar companies—Tiptree, Slide Insurance, and Colony Bankcorp—that show strong fundamentals and strategic momentum as we head into 2026.
Former President Trump claims tariff revenue can fund direct payments to Americans, bypassing Congress. Experts question the legality and economic feasibility of the proposal.
Despite a 129% share price surge, Cassiar Gold (CVE:GLDC) faces a critical test with a cash runway of just 8 months. We examine the risks and options for the pre-revenue miner as it balances growth ambitions with financial sustainability.
With major indices hovering near record levels and the Federal Reserve on hold, income-focused investors are turning to dividend payers for reliable returns. We analyze three standout stocks offering yields and stability as the market awaits tech earnings season.
Helport AI Limited (NASDAQ:HPAI) reports an 11% Return on Equity, notably below the software industry average. While low leverage offers some comfort, analysts are divided on whether this signals a cautious growth strategy or a fundamental performance gap.
EQ Resources (ASX:EQR) has seen its share price skyrocket over 120% in a month, fueled by renewed interest in tungsten and strategic project updates. As the market re-evaluates the critical minerals sector, we examine whether the company's current premium is justified or a sign of overheating sentiment.
As Medical Properties Trust (MPW) prepares to report earnings, a spike in short-dated call options and a move to new Birmingham headquarters have investors weighing the REIT's path to profitability against persistent financial risks.
Despite an 11% weekly share price drop, Smith Douglas Homes (SDHC) boasts a robust 19% Return on Equity, significantly outpacing the industry average. This divergence between market sentiment and financial health raises questions about short-term pressures versus long-term value.
The $7.6 billion RIA has expanded its internal equity plan to 29 employee-owners, formalizing a decade-long succession strategy that aims to preserve independence as co-founder Barry Ritholtz nears 65.
Building significant wealth often hinges on consistency over brilliance. We examine the Vanguard Growth ETF (VUG), its historical performance, and the disciplined, long-term strategy that could potentially transform regular savings into a seven-figure nest egg.
The home and security products leader raises its quarterly payout, offering a 1.9% yield. While cash flow coverage appears solid, analysts note the company's mixed dividend history and point to future earnings growth as a key sustainability factor.
While Alimentation Couche-Tard shareholders have enjoyed solid total returns over five years, a closer look reveals a growing disconnect between its stock performance and underlying profit growth, with recent underperformance adding to investor uncertainty.
Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
While speculative stories often captivate the market, Waterstone Financial (NASDAQ:WSBF) stands out with consistent profitability and disciplined leadership—traits gaining attention as investors prioritize fundamentals.
Eagle Materials Inc. (NYSE:EXP) boasts a Return on Equity nearly double the industry average. But as investors cheer the metric, a deeper look reveals a heavy reliance on debt, raising questions about the sustainability of its impressive performance.
